Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

Samuele Cortese, Martin Holtmann, Tobias Banaschewski, Jan Buitelaar, David Coghill, Marina Danckaerts, Ralf W Dittmann, John Graham, Eric Taylor, Joseph Sergeant, European ADHD Guidelines Group, Joseph Sergeant

Research output: Contribution to journalJournal articleResearchpeer-review

240 Citations (Scopus)

Abstract

Medication is an important element of therapeutic strategies for ADHD. While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs. The aim of this review is to provide evidence- and expert-based guidance concerning the management of (AEs) with medications for ADHD.
Original languageEnglish
JournalJournal of Child Psychology & Psychiatry
Volume54
Issue number3
Pages (from-to)227-46
Number of pages20
ISSN0021-9630
DOIs
Publication statusPublished - Mar 2013

Keywords

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity
  • Blood Pressure
  • Body Size
  • Cardiovascular Diseases
  • Central Nervous System Stimulants
  • Child
  • Clonidine
  • Dextroamphetamine
  • Growth Disorders
  • Guanfacine
  • Heart Rate
  • Humans
  • Methylphenidate
  • Propylamines
  • Psychoses, Substance-Induced
  • Seizures
  • Sleep Disorders
  • Substance-Related Disorders
  • Suicide
  • Tic Disorders
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents'. Together they form a unique fingerprint.

Cite this